Antipodes Emerging Markets (Managed Fund)

The Fund typically invests in a select number of attractively valued companies exposed to emerging markets or listed on emerging market stock exchanges (usually a minimum 30 long holdings).

This product is intended for use as a core allocation for a consumer who is seeking capital growth and has a high risk and return profile for that portion of their investment portfolio. It is likely to be consistent with the financial situation and needs of a consumer with a 5-year investment timeframe and who is unlikely to need to withdraw their money on less than one week’s notice.

Key facts

Investment manager Antipodes Partners Limited
Responsible entity Pinnacle Investment Management Limited
Strategy Emerging Markets
Investment Objective The aim of the Fund is to achieve absolute returns in excess of the Benchmark over the investment cycle (typically 3-5 years).
Benchmark MSCI Emerging Market Index
Suggested minimum investment period 5 years
Risk High
Portfolio Allocation1 75 - 100% Emerging market equities
0 - 25% Cash equivalent investments
Registration Australia & New Zealand
Dealing frequency & cut-off Daily / 12pm Sydney
Distribution frequency Annually, 30 June
Minimum initial investment A$25,000
Minimum additional investment A$5,000
Strategy inception date 1 July 2015
ISIN AU60IOF02030
APIR IOF0203AU
ARSN 096 451 393

1The portfolio allocation ranges provided are indicative only. The Fund will be rebalanced within a reasonable period of time should the exposure move outside these ranges.

Net performance

All returns are net of fees and in AUD terms. Past performance is not a reliable indicator of future performance. 1The inception date is the date that the current investment strategy was adopted (1 October 2022). 2MSCI Emerging Markets Index in AUD.

Performance chart

Cumulative performance (over selected time horizon)

All returns are net of fees and in AUD terms. Calculations are based on exit price with distributions reinvested, after ongoing fees and expenses but excluding taxation. Past performance is not a reliable indicator of future performance. The inception date is the date that the current investment strategy was adopted (1 October 2022).

Unit price history

Distribution history

 

Portfolio profile as at 31st May 2024

Top 10 equity longs (%)

Sector exposure (%)2

Currency exposure (%)1, 3

Regional exposure (%)1, 3

1 Where possible, regions, countries and currencies classified on a look through basis. 2 GICS Classification. 3 Antipodes Partners classification.

Monthly updates

For historical reports, please contact the Antipodes team

Quarterly updates

For historical reports, please contact the Antipodes team

mFund

Annual Financial Statement

Other Documents

Invest

If you are applying online, or using paper application forms, the minimum investment in the Antipodes Emerging Markets (Managed Fund) is $25,000 for new investors and $5,000 for existing investors.


Who may invest in the fund

This fund is open to investors from Australia and New Zealand. For international investors, please visit our international page for investment options.

Online applications are available for individuals, partnerships, SMSFs, superannuation funds and other regulated trusts and companies. Applications for unregulated trusts, (such as family and testamentary trusts) cannot be completed online and should make use of the paper based application form in the ‘All forms’ section of this page.


Important information

It is a legal requirement to download and read the Product Disclosure Statement before proceeding and we recommend that you consult a licensed financial advisor before making investment decisions.

Download Product Disclosure Statement.

Download Target Market Determination (TMD).


Apply online

The application below allows you to open an account with our distribution partner; Pinnacle Investment Management Group Pty Ltd (‘Pinnacle’), who focus on providing superior investment services and delivering investment excellence.

  1. Select your account type
  2. Complete the application form, selecting the relevant fund
  3. Verify your identity online (use your Drivers Licence)
  4. Submit the application
  5. Separately make a secure payment from your bank account to the Trustee

Receive live email notifications as the application is processed.

Financial advisers:

Apply online

Individual investors:

Apply online

 


Apply via a paper form

Purchase, top-up or sell a managed fund investment the familiar way.

  1. Download an application form here
  2. Complete the application form & sign
  3. Provide certified copies of your identity to verify your identity
  4. Post original form and certified documents to:
    Antipodes Emerging Markets (Managed Fund)
    C/ Citi Unit Registry Australia
    GPO 764
    MELBOURNE
    VIC 3001
  5. Separately make a secure payment from your bank account to the Trustee

Download an application form.

Ratings

The Antipodes Emerging Markets (Managed Fund) has been rated “Recommended” by Zenith Investment Partners and “Investment Grade” by Lonsec Research.

 

   

 

Important information

This webpage is prepared by Antipodes Partners Limited (‘Antipodes’) (ABN 29 602 042 035 , AFSL 481 580) as the investment manager of the Antipodes Emerging Markets (Managed Fund) (ARSN 096 451 393) (the ‘Fund’). Pinnacle Fund Services Limited (‘PFSL’) (ABN 29 082 494 362, AFSL 238 371) is the product issuer of the Fund. PFSL is not licensed to provide financial product advice. PFSL is a wholly-owned subsidiary of the Pinnacle Investment Management Group Limited (‘Pinnacle’) (ABN 22 100 325 184) .

The information provided in this website is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Fund, you should consider the current Product Disclosure Statement (PDS) and Target Market Determination (‘TMD’) of the Fund and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at www.asx.com.au, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser.

Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Fund. There can be no assurance that the Fund will achieve its investment objectives. The value of your units at any point in time may be worth less than your original investment even after taking into account the reinvestment of Fund distributions. Returns are not guaranteed, and you may lose some or all of your money. The specific risks associated with investing in the Fund, and the risks associated with the Fund’s investments, are discussed in Section 6 of the Product Disclosure Statement. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this website. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance.

The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned  Antipodes Emerging Markets (Managed Fund) – November 2022) referred to on this website is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.

The Lonsec Ratings (assigned as follows: Antipodes Emerging Markets (Managed Fund) – June 2023) presented in this document are published by Lonsec Research presented in this document are published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421445. The Ratings are limited to “General Advice” (as defined in the Corporations Act 2001 (Cth)) and based solely on consideration of the investment merits of the financial products. Past performance information is for illustrative purposes only and is not indicative of future performance. They are not a recommendation to purchase, sell or hold Antipodes products, and you should seek independent financial advice before investing in these products. The Ratings are subject to change without notice and Lonsec assumes no obligation to update the relevant documents following publication. Lonsec receives a fee from the Fund Manager for researching the products using comprehensive and objective criteria. For further information regarding Lonsec’s Ratings methodology, please refer to our website at https://www.beyond.lonsec.com.au/intelligence/lonsec-ratings.